This move is another step in Makary’s attempts to shorten FDA reviews, which started when he began his tenure last year. 3 These include mandating the use of artificial intelligence for staffers and ...

The trouble with FDA's move to require only one study for new drugs ...

Drug sponsors should nevertheless bolster their application with “confirmative evidence,” chief regulators Marty Makary and Vinay Prasad said on Wednesday, including mechanistic data or findings from ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. The first ...

Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...